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Abstract: FORS-D is a measure of the contribution of base order to the stem loop potential of a nucleic acid sequence and can also 
give information on evolutionary pressures on sequences to move away from secondary structure. Negative FORS-D values in a gene 
are associated with exons and nucleotide substitutions such as SNPs. An analysis of P. falciparum genes under selection pressure shows 
a correlation between negative FORS-D values and SNP density for genes that drug targets but not for drug transporters or antigenic 
variation genes. Analysis of the dhfr gene shows that a majority of rare mutations that associate with drug resistance also fall into regions 
with negative FORS-D values. These data suggest that FORS-D values might be predictors for drug target genes and drug resistance 
mutations in these genes.
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Introduction
The  protozoan  parasite  Plasmodium  falciparum 
causes severe malaria resulting in millions of deaths 
world-wide,  a  problem  exacerbated  by  the  emer-
gence of resistance to almost all known anti-malarial 
drugs.1 Drug resistance has arisen through acquisition 
of mutations in drug targets and in drug transporters.2 
For example, mutations in the target genes dihydro-
folate reductase (dhfr) and dihydropteroate synthase 
(dhps) led to resistance against the   anti-folate drugs 
pyrimethamine and sulphadoxine, while mutations in 
transporters pfcrt and pfmdr1 resulted in resistance to 
chloroquine and quinine.3 Apart from specific drug 
resistance mutations, high frequencies of single nucle-
otide polymorphisms (SNPs) are seen in genes encod-
ing drug targets, transporters and cell surface antigenic 
genes, suggesting that genes under selection are highly 
polymorphic giving rise to a survival advantage.4 Fur-
ther, genes under selection pressure also exhibit high 
ratios  of  synonymous  (S)  to  non-synonymous  (N) 
mutations.5 These studies on genome-wide diversity 
have also identified potential new drug targets.6
Once  a  drug  target  is  identified,  new  drugs 
  developed and deployed, the high genetic diversity of 
P. falciparum could result in acquisition of new muta-
tions, potentially resulting in drug resistance. Indeed, 
anti-malarials  like  atovaquone  succumbed  to  this 
problem in disturbingly short time frames.7 Hence, it 
would be of interest to find genome features that asso-
ciate with polymorphisms and resistance   mutations 
in the hope that one could predict genetic variation 
especially for drug target genes.
One such genome feature that has been shown to 
associate with genetic variations, especially for genes 
under selection, is a parameter known as   FORS-D.8 
In brief, the ability of a DNA sequence to form a 
  stable secondary structure can be predicted by the 
free energy of folding (∆G) of the sequence, with a 
negative ∆G value indicating more stable secondary 
  structure.   Forsdyke has termed this ∆G value of the 
natural sequence as Folding of the Natural Sequence 
(FONS).  However,  negative  ∆G  values  might  be 
observed simply due to base composition bias such as 
high GC   content and have little to do with the sequence 
perse. To account for this, the same sequence is ran-
domized and the average ∆G value of the   randomized 
sequences  is  computed  (Folding  of  Randomized 
Sequences-Mean  or  FORS-M).  The  difference 
between  FORS-M  and  FONS  is  termed  FORS-D 
(Folding  of  Randomized    Sequences-Difference). 
Thus FORS-D is the base order dependant stem loop 
potential of a particular sequence.
A positive FORS-D value for a given sequence 
implies  a  pressure  towards  maintaining  secondary 
structure  in  that  part  of  the  genome.  Conversely, 
regions of the genome exhibiting negative FORS-D 
values may be sequences where there is an evolution-
ary  pressure  to  move  away  from  stable  secondary 
structures. Forsdyke’s work has shown that coding 
regions are associated with negative FORS-D val-
ues compared to introns since the presence of amino 
acid codons clearly has a high priority over second-
ary structure.9,10 Interestingly, sequences that undergo 
substitutions in genes under selection also show nega-
tive FORS-D values, implying that selection pressure 
can override secondary structure constraints.8,11
In this report we ask whether FORS-D is correlated 
with SNPs in P. falciparum genes. For this analysis, 
a modified version of the Random Scan software12 
was developed. Using this software called SNP Scan, 
we  analyzed  genes  that  are  associated  with  drug 
  resistance ie, dhfr, dhps, pfmdr1 and pfcrt and genes 
from the family of antigenic variable proteins (var) 
that are under selection pressure from the host immune 
response. The results of the analysis show that for 
genes encoding drug targets there is a   negative corre-
lation between FORS-D values and variation (SNPs, 
drug  resistance  mutations  and  rare  drug  resistance 
mutations)  reinforcing  similar  data  from  previous 
studies. These data suggest that FORS-D is a feature 
that can be used to predict gene sequences that are 
hotspots for substitutions and mutations. Surprisingly, 
genes that encode transporters associated with drug 
resistance do not show negative correlations between 
FORS-D and SNPS that are seen for genes that encode 
drug targets; similarly most genes encoding variable 
surface antigens also do not show   negative correla-
tion  between  SNPS  and  FORS-D.  Similar  results 
were obtained with Random Scan software. Hence 
unlike  SNP  density  and  non-synonymous  SNPs, 
FORS-D correlation with SNPs appears to be specific 
for drug target genes. To test this hypothesis we ana-
lyzed a gene that has been implicated in resistance to 
artemisinin, the P. falciparum ATPase 6 gene. This 
gene also shows a high negative correlation between 
SNPs and FORS-D   values. We propose that FORS-D FOrS-D analysis of P. falciparum genes
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analysis of the genome may reveal targets of drugs 
such as chloroquine;   furthermore, FORS-D analysis 
of novel drug target genes may reveal early insights 
into drug resistance.
Materials and Methods
DnA sequences and SnPs
All DNA and SNP data was downloaded from    Plas-
moDB.13 The dhfr-ts, pppk-dhps (PF08_0095), pfmdr1 
(PFE1150w),  pfcrt  (MAL7P1.27)  genes,  pfatpase6 
(PFA0310c) and 8 var genes (Mal13p1_405, PF11_0008, 
PFD0020c,  PFB0020c,  PFF1580c,  PFF0845c, 
PFL0935c) were chosen for individual FORS-D analy-
ses. DNA sequences of these genes were downloaded 
from  PlasmoDB  version  6  (www.plasmodb.org). All 
sequences used for FORS-D analysis were from the ref-
erence 3D7 genome.
SNPs and their location on each DNA sequence 
were also downloaded from PlasmoDB version 6. For 
assignment of SNPS to FORS-D windows, the loca-
tion of each SNP was noted as were the number of 
strains each SNP was found in. Of note, all strains 
from PlasmoDB were selected during the download, 
including P. reichenowi since inclusion of this pri-
mate parasite gave higher numbers of SNPs and sta-
tistical power to the analysis. Further, the genome of 
P. reichenowi is is closest to P. falciparum in terms of 
phylogenetic distance and many genes are conserved. 
The total number of SNPs in a window was the sum 
of all SNPs found in different strains.
FOrS-D and statistical analysis
For the purpose of carrying out FORS-D analysis, 
SNP Scan 2.0 (beta) software was developed. DNA 
sequences without introns ie, cDNA sequences were 
downloaded from PlasmoDB and were fed as input 
to SNP Scan 2.0. The software reads the sequence in 
steps of windows (each 200 nts wide) sliding   forward 
by 50 nts. Hence, consecutive windows overlap by 
150 nts. The software calculates FONS values for 
each of these windows by folding 100 nts against 
each  other  from  within  the  200  nts  long  window. 
FORS-M values are calculated by randomizing the 
natural sequence and taking the average of fold ener-
gies, all of which is coded into the software. The code 
  generates 1000 randomized sequences, for the sake 
of accuracy, although 10 randomizations are known 
to serve the purpose.12 The FORS-D values are then 
evaluated by the software by means of the following 
equation:
FONS = FORS-M - FORS-D
The stem loop potential associated with a given 
sequence is approximated by means of Tinoco’s sta-
bility numbers. A-T base paring is assigned a value 
of 1 units and G-C base pairing in the given sequence 
is assigned value of 2 units. A sum of these pairings 
for a given stretch of nucleotides gives the stem loop 
potential (FONS) for the given sequence.
SNP  Scan  2.0  was  developed  as  the  long  term 
goal of this study was to use the software on genomic 
sequences,  although  this  preliminary  analysis  used 
individual genes. SNP Scan 2.0 does not get into time 
consuming  calculations  of  actual  base  stacking  and 
loop destabilization energies of secondary structures. 
Instead, it draws a robust relative picture of the variations 
in FORS-D values of various windows, based on the 
sequence specific A-T and G-C Tinoco’s stability num-
bers. The Tinoco stability number  approximations,14 
which our software uses, are well documented.15 As 
a result, SNP Scan 2.0 has a faster turnaround time 
than other software. The SNP scan code is available at 
http://www.bio.iitb.ac.in/∼patankar/
Since the software generated FORS-D values for 
overlapping windows, for each window we assigned a 
number that was the average of the window viz. win-
dow 1–200 was assigned a value of 100, while window 
50–250 was assigned a value of 150, etc. For correlation 
analysis, for each DNA sequence the number of SNPs 
and the corresponding FORS-D value was computed. 
Correlation between these two variables was performed 
using the statistical features in Microsoft Excel spread-
sheets, SPSS and MiniTab software packages.
Results
SnPs and drug resistance mutations 
associate with negative FOrS-D values 
for dhps and dhfr
FORS-D has been shown to correlate with SNPs in 
genes  under  selection  for  snake  venom  and  MHC 
genes and for retroviral genomes.8,11,16 To test whether 
this was true for P. falciparum drug resistance genes, 
two drug target genes viz. dhps and dhfr were   analyzed. 
The proteins encoded by these genes are the only two 
validated drug targets of anti-malarial drugs known to 
date; although it would have been optimal to analyze Kathpal et al
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several drug target genes, the lack of such numbers 
precluded a wider analysis. The pppk-dhps locus was 
subjected to FORS-D analysis with SNPs and drug 
resistance mutations mapped onto the FORS-D graph 
(Fig. 1A). Both positive and negative FORS-D values 
as well as numerous SNPs can be seen through the 
length of this gene.
A large number of SNPs are associated with nega-
tive FORS-D regions in this gene. The majority of 
drug resistance mutations (S436, A437, A581) were 
also  associated  with  negative  FORS-D  regions  of 
pppk and dhps. These data indicate that both SNPs 
and drug resistance mutations associate with regions 
of negative FORS-D in the dhps gene. A similar anal-
ysis was performed for the dhfr-ts gene (Fig. 1B). In 
contrast to pppk-dhps, SNPs are found predominantly 
in dhfr and not in ts. Nevertheless, SNPs were associ-
ated with negative FORS-D regions. The five most 
commonly studied drug resistance mutations in the 
dhfr gene are A16, V51, C59, S108 and I164 as com-
binations of these mutations result in varying levels 
of pyrimethamine resistance in biochemical enzyme 
assays,  in  vivo  drug  resistance  assays  and    clinical 
phenotypes.17,18  Four  out  of  five  drug  resistance 
  mutations (A16, V51, C59, S108) were also associ-
ated with regions of negative FORS-D.
Recent reports have identified rare drug resistance 
alleles of dhfr by isolation of the gene from clinical 
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Figure 1. FOrS-D analysis of the pppk-dhps locus (A) and the dhfr-ts locus (B). The y-axis shows the folding energy in Tinoco stability numbers of each 
100 base window. The x-axis represents the sequence of the gene. SnPs are shown as blue circles and drug resistance mutations as red circles. Amino 
acid changes that have been shown to cause drug resistance are indicated in red. Rare mutations found in field isolates are shown in black.
samples and functional complementation of a yeast 
strain with a dhfr deletion.19,20 We asked whether these 
the mutations identified in these rare alleles also map 
to negative FORS-D regions of the dhfr gene. Results 
shown in Figure 1B (mutations shown in black) indi-
cate that although the rare drug resistance alleles are 
found at distinct positions on the gene, four out of six 
rare mutations map to regions with negative FORS-D 
values. Similarly, a novel SNP (S587F) in the dhps 
gene21  also  maps  to  a  negative  FORS-D  window 
(window 1950–2000) as indicated in Figure 1A.
negative correlation between  
SnP density and FOrS-D  
for drug resistance genes
Having shown that SNPs and drug resistance muta-
tions are associated with regions of negative FORS-D 
for two drug target genes, we next asked whether there 
is a statistical correlation between SNP   density and 
FORS-D values for drug resistance genes.   Correlation 
would suggest a linear relationship between the two 
variables  and  although  no  indication  of  causality, 
might allow the use of one variable (FORS-D) to pre-
dict the second variable (SNPs). We analyzed dhfr-ts 
and pppk-dhps and included pfcrt and pfmdr1, the 
transporters shown to confer resistance to quinoline 
drugs. Table 1 shows a negative correlation between 
SNP density and FORS-D value for two genes   studied FOrS-D analysis of P. falciparum genes
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[dhfr (-0.24), dhps (-0.17)] and a positive correlation 
for the pfmdr1 gene (0.23). In contrast, no correlation 
between FORS-D values and SNPs was observed for 
pfcrt (0.09). Although the negative correlation val-
ues are relatively small, they are comparable with 
results seen in other reports that analyze FORS-D 
and variation.10,16
This result suggests that for genes which encode 
drug targets and hence are under selection pressure, 
SNP density is correlated to a numerical parameter 
(FORS-D) that indicates a propensity to move away 
from stable secondary structure. However, for other 
genes that are also under selection pressure such as 
drug  resistance  transporters,  there  is  poor  or  posi-
tive correlation between FORS-D and SNP density. 
We next tested whether the pfatpase6 gene that has 
been  implicated  in  in  vitro  resistance  to  artemisi-
nin also shows negative correlation between SNPs 
and  FORS-D  values.  Interestingly,  this  gene  also 
shows a negative correlation (-0.20) between these 
two parameters, suggesting that perhaps this gene is 
indeed under selection pressure from the drug.
To  confirm  the  results,  we  used  the  Random 
Scan software developed by Zhang et al to compute 
FORS-D  values  of  the  four  genes.12  The  Random 
Scan software subtracts the FORS-M value from the 
FONS value (opposite to our software) hence with 
this software a positive value reflects the propensity 
to move away from secondary structure. A similar 
result was obtained with the Random Scan software 
viz.  drug  target  genes  show  a  positive  correlation 
between  FORS-D  and  SNP  density  indicating  that 
SNPs are found in regions that are under evolutionary 
pressure to move away from stable secondary struc-
tures  (Table  1).  In  contrast  the  genes  that  encode 
drug transporters do not show this property. Since the 
results obtained by the SNP Scan 2.0 software were 
similar to those from Random Scan, SNP Scan 2.0 
was used for the remainder of the study.
Low negative correlation between SnP 
density and FOrS-D for var genes
Genes  under  selection  show  a  negative  correla-
tion between SNP density and FORS-D, suggesting 
that sequences with low base order dependent stem 
loop potential are associated with higher variation. 
To assess whether this is true of other genes under 
positive selection, we performed FORS-D analysis 
of 8 var genes that encode proteins involved in anti-
genic variation. These 8 genes were selected based 
on literature that showed that these genes are indeed 
expressed in a mutually exclusive manner during lab 
culture of P. falciparum.22–26
PfEMPs are parasite-encoded proteins found on 
the  surface  of  infected  blood  cells.  By  switching 
the PfEMP that is expressed the parasite can evade 
immune responses leading to some of the pathogenic 
phenotypes of P. falciparum.27 Hence, these proteins 
are under selection pressure, however the response of 
the parasite to host immune pressure is at the level of 
transcriptional and epigenetic control of gene expres-
sion although var genes do show high frequencies 
of SNPs.28 Analysis of individual var genes located 
at sub-telomeric and internal positions on different 
chromosomes (Table 2) indicated that most var genes 
studied did not show a strong negative correlation 
between FORS-D values and SNP density. However 
two genes (PFF1580c and PFF0845c) showed a corre-
lation coefficient of -0.12 and -0.11. Based on results 
of drug targets, we speculate that these var genes may 
Table 1. correlation between number of SnPs and FOrS-D values associated with each SnP for drug resistance genes. 
The four genes were analyzed using SnP Scan 2.0 software where negative FOrS-D values indicate that the sequence is 
under evolutionary pressure to accommodate substitutions. The random Scan software differs from SnP Scan 2.0 in that 
a sequence under evolutionary pressure to accommodate SnPs would show a positive FOrS-D value. Pearson correlation 
coefficients for SNPs and FORS-D are shown as are the chromosome numbers for each gene.
Gene chromosome Pearson correlation coefficient 
snp scan program Random scan FORs-D program
dhfr-ts 4 -0.24 0.122
pppk-dhps 6 -0.17 0.22
pfmdr1 5 0.23 -0.061
Pfcrt 7 0.09 -0.017Kathpal et al
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be under selection to alter the DNA sequence such 
that  the  encoded  PfEMP1  proteins  exhibit  altered 
binding to the host receptors. In conjunction with the 
data on drug target genes and drug transporters, this 
data suggests that correlation between FORS-D and 
SNP density appears to be able to differentiate the 
type of selection pressure on a given gene.
Discussion
The SnP Scan software shows  
negative correlations between FOrS-D 
values and SnPs for P. falciparum drug 
target genes
The SNP Scan software performed similar to Ran-
dom Scan at assigning FORS-D values that showed 
inverse  correlations  with  the  presence  of  SNPs  in 
P. falciparum drug target genes. The SNP Scan tool 
is based on a time-efficient algorithm to evaluate ran-
domizations of windows of nucleotides and perform 
the appropriate calculations of FONS, FORS-M and 
FORS-D values, in that particular order. It approxi-
mates and predicts the relative differences in the fold-
ing  energies  based  on  Tinoco  stability  numbers.15 
SNP Scan simplifies the procedure of evaluating fold-
ing energies, concentrating on relative variation in 
FORS-D values over the windows, rather than evalu-
ating the absolute folding energies for every window 
and has the advantage of rapid data output.
Additionally, for the  AT-rich genome of P. falciparum 
we  observed  that  SNP  Scan  analysis  gives  rela-
tively flat curves for FORS-M shown for dhfr-ts and   
pppk-dhps (Figs. 1A and 1B) and observed for all the 
other genes tested. This results in FORS-D values 
essentially giving the same trend as the FONS curve 
for our analysis and hence, SNPs would also show a 
strong correlation with FONS. As FONS is simply the 
folding of the natural sequence, Tinoco stability num-
bers from SNP Scan data suggest that P. falciparum 
SNPs are found in regions of drug target genes that 
show lower FONS values are hence have less stable 
secondary structure. These observations suggest that 
FONS alone may be sufficient to predict SNPs in the 
P. falciparum genome.
negative FOrS-D values may predict 
SnPs and drug resistance mutations
There is a negative correlation between SNP density 
and FORS-D values for the drug target genes dhfr-ts 
and pppk-dhps (Table 1) and the putative drug tar-
get  pfatpase6.  Correlation  of  SNPs  with  negative 
FORS-D values has been shown previously for viral 
genomes, snake venom genes and MHC genes.8,11,16 
Hence, it has been proposed that genes under selec-
tion have regions that show a propensity to move 
away from stable secondary structure. Such correla-
tion analyses provide valuable data, however cause 
and effect is impossible to discern ie, are SNPs caused 
due  to  sequence  constraints  in  regions  with  nega-
tive FORS-D values or conversely are the negative 
FORS-D values caused due to SNPs?
Results of this study indicate that for P. falciparum, 
regions of genes that have negative FORS-D values 
may have a higher predisposition to acquire SNPs. We 
propose this cause and effect relationship for the fol-
lowing reasons. The sequence that was analyzed for 
generating FORS-D values is the 3D7 strain genome 
sequence; 3D7 parasites are sensitive to anti-malarial 
drugs and their genome should not show signatures 
Table 2. correlation between number of SnPs and FOrS-D values associated with each SnP for var genes. chromosome 
number and chromosomal location (sub-telomeric and internal) are indicated. Pearson correlation coefficients were calcu-
lated for SnP density versus FOrS-D values using the SnP Scan 2.0 software.
pfeMp gene chromosome Pearson correlation coefficient chromosomal location
PF11_0008 11 0.08 Sub-telomere
PFD0020c 4 0.02 Sub-telomere
PFF1580c 6 -0.12 Sub-telomere
PFF0845c 6 -0.11 internal
PFL0935c 12 -0.01 internal
PF07_0049 7 -0.03 internal
PFD1015c 4 0.00 internal
PFB1055c 2 -0.01 Sub-telomereFOrS-D analysis of P. falciparum genes
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of selection pressure. Secondly, SNPs were obtained 
from  all  strains  of  P.  falciparum  and  also  from 
P. reichenowi where available. If SNPs from a closely 
related  primate  parasite  are  also  found  in  regions 
of negative FORS-D values, this implies that those 
regions  of  the  drug  target  genes  may  indeed  have 
sequence characteristics that promote variability. Thus 
the data suggest that dhfr-ts and pppk-dhps genes have 
hotspots for mutation that can be predicted by nega-
tive FORS-D values. To address this possibility, we 
studied rare SNPs19,20 that have been detected in drug 
resistant parasites by a novel yeast complementation 
assay for dhfr. If regions of negative FORS-D in a 
gene do indeed predispose those sequences to higher 
variation, the rare SNPs should also fall into FORS-D 
negative windows in the dhfr gene. Indeed, four out of 
six rare SNPs (Fig. 1B), were associated with negative 
FORS-D windows. One rare mutation in the dhps gene 
was also associated with a negative FORS-D window 
(Fig. 1A). These data suggest that FORS-D may be 
able to predict regions in genes under selection that 
may be mutational hotspots; such hotspots have been 
suggested for dhfr29 and may be true for dhps as well.
If  the  prediction  that  negative  FORS-D  values 
indicate mutational hotspots in genes under selection 
is correct, a FORS-D analysis of genes that are tar-
gets of future drugs may be able to predict hotspots 
for SNPs and drug resistance mutations. A case in 
point  is  the  deoxy-xylulose  phosphate  reductoi-
somerase (dxpr) gene, the target of an anti-malarial 
drug,  fosmidomycin  that  is  in  clinical  trials.  The 
dxpr gene has only 2 SNPs in PlasmoDB however a 
recent paper30 has found 5 amino acid substitutions 
in dxpr (not associated with drug resistance) in clini-
cal samples. Correlation of these with FORS-D gives 
a Pearson coefficient of -0.85. Although dxpr resis-
tance in vitro so far appears to be through duplication 
of the gene,31 we speculate that SNPs may appear in 
negative FORS-D regions of this gene and if these 
regions  have  amino  acids  that  affect  drug  binding 
they may give rise to resistance. This would be simi-
lar to pfmdr1 where increased copy number is associ-
ated with mefloquine resistance32,33 however specific 
mutations have been shown to confer resistance to 
mefloquine, quinine and halofantrine.34 We propose 
that FORS-D analysis may become part of the analy-
sis of future drug targets.
What might be the biological significance of the 
negative correlation observed between FORS-D and 
SNPs? DNA sequences analyzed here would be double 
stranded throughout the life cycle of the parasite except 
during  DNA  replication  where  the  single-stranded 
DNA could potentially form transient stem loops. We 
speculate that low FORS-D values suggest a low sec-
ondary structure context and perhaps the DNA replica-
tion machinery incorporates variations in such regions. 
Alternative explanations for high variation in regions 
of low secondary structure include potential for recom-
bination during the meiotic stages of the parasite life 
cycle (sexual stages formed in the mosquito) where 
weak secondary structure may allow recombination.
FOrS-D analysis can distinguish 
between different responses  
to selection pressure
Whole genome SNP mapping has shown that genes 
having a higher frequency of SNPs and a higher ratio 
of  synonymous  to  non-synonymous  mutations  are 
under selection and hence may be potential drug and 
vaccine targets.4,31,35 In this report we show that there is 
a negative correlation between FORS-D values, SNP 
density and known drug resistance mutations for the 
dhfr-ts and pppk-dhps genes that are under selection 
pressure. However two other genes also under selec-
tion pressure (pfmdr and pfcrt) do not show a negative 
correlation. Some reasons for these differences could 
be relative GC and purine content of the four genes, 
features that might result in differences in FORS-D 
values; however, analysis of GC and purine content 
showed that there is no statistical difference between 
these parameters in the four genes (data not shown).
Another difference between dhfr-ts, pppk-dhps and 
pfmdr, pfcrt is that the former are drug targets while 
the latter are drug transporters. This led to the hypoth-
esis that negative FORS-D values may be associated 
with  certain  classes  of  genes,  especially  those  that 
directly bind to ligands or proteins. To test this hypoth-
esis, another class of genes that is also under selection 
pressure was studied: the antigenic variation or var 
genes. Most var genes showed no correlation between 
FORS-D and SNP density except for two genes.
Although  drug  targets,  drug  transporters  and 
var  genes  all  are  under  selection,  there  is  a  fun-
damental  difference  between  the  response  of  var Kathpal et al
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genes and drug resistance genes to selection pres-
sure in P. falciparum. Drug resistance genes in the 
parasite respond to selection pressure by acquiring 
mutations17,18 while some drug transporters such as 
pfmdr show increased copy number in response to 
drug pressure.32,33 In a completely different mech-
anism,  var  genes  respond  to  selection  pressure 
through  switching  at  the  level  of  transcription  or 
through epigenetic mechanisms.27,28 It is interesting 
that correlations between SNP density and FORS-D 
values  appear  to  differentiate  between  different 
types of responses to selection pressure.
Several studies have shown that SNP density and 
dN/dS ratios can reveal genes that are under selection 
and var genes fall into this category.4 Simply   looking 
at  SNP  density  of  a  gene  or  dN/dS  ratios  does  not 
distinguish the types of responses to selection pressure. 
  However,  data  shown  in  this  report  suggests  that  a 
  negative   correlation between SNP density and FORS-D 
values indicates genes under selection pressure to acquire 
mutations such as the drug target genes dhfr and dhps. 
The observation that some var genes also show nega-
tive correlation between FORS-D and SNP density sug-
gests that these var genes acquire mutations in response 
to the selective pressure imposed by the host immune 
system. As a future application of FORS-D analysis, 
genome-wide scans for genes that show high negative 
correlation between FORS-D and SNP density may be 
a strategy to identify drug targets that have yet to be 
discovered viz. the target of chloroquine. In an attempt 
to do precisely this, we subjected the pfatpase6 gene to 
FORS-D analysis and showed that this gene also shows 
a  negative  correlation  between  FORS-D  values  and 
SNPs. These data suggest that the pfatpase6 gene that 
has been implicated in resistance to artemisinin in vitro 
may indeed be the target of the drug.
In conclusion, given the rapid acquisition of drug 
resistance, it would be immensely useful to be able 
to predict sequences that are susceptible to selection 
pressure and undergo variation in the malaria parasite 
genome sequence. FORS-D analysis will be an excel-
lent starting point to uncover genes that are under 
selection pressure and analyze drug target genes for 
signatures of variation in P. falciparum.
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